eylea hd

Generic: aflibercept

Labeler: regeneron pharmaceuticals, inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name eylea hd
Generic Name aflibercept
Labeler regeneron pharmaceuticals, inc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVITREAL
Active Ingredients

aflibercept 8 mg/.07mL

Manufacturer
Regeneron Pharmaceuticals, Inc

Identifiers & Regulatory

Product NDC 61755-050
Product ID 61755-050_d36e4177-a5ec-4bba-9639-90510fa725de
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761355
Listing Expiration 2026-12-31
Marketing Start 2023-08-18

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 61755050
Hyphenated Format 61755-050

Supplemental Identifiers

RxCUI
2645305 2645308
UNII
15C2VL427D
NUI
N0000193543 N0000193542

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eylea hd (source: ndc)
Generic Name aflibercept (source: ndc)
Application Number BLA761355 (source: ndc)
Routes
INTRAVITREAL
source: ndc

Resolved Composition

Strengths
  • 8 mg/.07mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-050-01) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-050-00)
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-050-51) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-050-50)
source: ndc

Packages (2)

61755-050-01 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-050-01) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-050-00) 61755-050-51 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-050-51) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-050-50)

Ingredients (1)

aflibercept (8 mg/.07mL)

Linked Drug Pages (1)

EYLEA HD ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVITREAL"], "spl_id": "d36e4177-a5ec-4bba-9639-90510fa725de", "openfda": {"nui": ["N0000193543", "N0000193542"], "unii": ["15C2VL427D"], "rxcui": ["2645305", "2645308"], "spl_set_id": ["86d8848b-111b-4da9-8957-7cccef1b8f66"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-050-01)  / .07 mL in 1 VIAL, SINGLE-DOSE (61755-050-00)", "package_ndc": "61755-050-01", "marketing_start_date": "20230818"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-050-51)  / .07 mL in 1 VIAL, SINGLE-DOSE (61755-050-50)", "package_ndc": "61755-050-51", "marketing_start_date": "20230818"}], "brand_name": "EYLEA HD", "product_id": "61755-050_d36e4177-a5ec-4bba-9639-90510fa725de", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "61755-050", "generic_name": "aflibercept", "labeler_name": "Regeneron Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EYLEA HD", "active_ingredients": [{"name": "AFLIBERCEPT", "strength": "8 mg/.07mL"}], "application_number": "BLA761355", "marketing_category": "BLA", "marketing_start_date": "20230818", "listing_expiration_date": "20261231"}